The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
Open accessAbstract
Background: Steroid use for coronavirus disease 2019 (COVID-19) is based on the possible role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to evaluate the efficacy of methylprednisolone (MP) among hospitalized patients with suspected COVID-19. Methods: A parallel, double-blind, placebo-controlled, randomized, Phase IIb clinical trial was performed with hospitalized patients aged ≥18 years with clinical, epidemiological, and/or radiological suspected COVID-19 at a tertiary care facility in Manaus, Brazil. Patients were randomly allocated (1:1 ratio) to receive either intravenous MP (0.5 mg/kg) or placebo (saline solution) twice daily for 5 days. A modified intention-to-treat (mITT) analysis was conducted. The primary outcome was 28-day mortality. Results: From 18 April to 16 June 2020, 647 patients were screened, 416 were randomized, and 393 were analyzed as mITT, with 194 individuals assigned to MP and 199 to placebo. SARS-CoV-2 infection was confirmed by reverse transcriptase polymerase chain reaction in 81.3%. The mortality rates at Day 28 were not different between groups. A subgroup analysis showed that patients over 60 years old in the MP group had a lower mortality rate at Day 28. Patients in the MP arm tended to need more insulin therapy, and no difference was seen in virus clearance in respiratory secretion until Day 7. Conclusions: The findings of this study suggest that a short course of MP in hospitalized patients with COVID-19 did not reduce mortality in the overall population. Clinical Trials Registration: NCT04343729.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
SARS-CoV-2 Infection in Children
Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,431
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,008
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
Liu, K., Fang, Y.-Y., Deng, Y., Liu, W., Wang, M.-F., Ma, J.-P., Xiao, W., Wang, Y.-N., Zhong, M.-H., Li, C.-H., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000744 · Cited by 1,411
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Liu, B., Li, M., Zhou, Z., Guan, X., & Xiang, Y. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102452 · Cited by 763
Torres, A., Sibila, O., Ferrer, M., Polverino, E., Menendez, R., Mensa, J., Gabarrús, A., Sellarés, J., Restrepo, M. I., Anzueto, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.88 · Cited by 571
How to Use a Subgroup Analysis: Users’ Guide to the Medical Literature
Sun, X., Ioannidis, J. P. A., Agoritsas, T., Alba, A. C., & Guyatt, G. (2014) · JAMA · doi:10.1001/jama.2013.285063 · Cited by 550
Xu, K., Chen, Y., Yuan, J., Yi, P., Ding, C., Wu, W., Li, Y., Ni, Q., Zou, R., Li, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa351 · Cited by 501
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19
Fadel, R., Morrison, A. R., Vahia, A., Smith, Z. R., Chaudhry, Z., Bhargava, P., Miller, J., Kenney, R. M., Alangaden, G., Ramesh, M. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa601 · Cited by 463
Ni, Y.-N., Chen, G., Sun, J., Liang, B.-M., & Liang, Z.-A. (2019) · Critical Care · doi:10.1186/s13054-019-2395-8 · Cited by 391
Corticosteroid treatment of patients with coronavirus disease 2019 ( COVID ‐19)
Zha, L., Li, S., Pan, L., Tefsen, B., Li, Y., French, N., Chen, L., Yang, G., & Villanueva, E. V. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50577 · Cited by 344
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
Ciceri, F., Castagna, A., Rovere-Querini, P., De Cobelli, F., Ruggeri, A., Galli, L., Conte, C., De Lorenzo, R., Poli, A., Ambrosio, A., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108509 · Cited by 293
Li, H., Chen, C., Hu, F., Wang, J., Zhao, Q., Gale, R. P., & Liang, Y. (2020) · Leukemia · doi:10.1038/s41375-020-0848-3 · Cited by 265
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
Zhou, W., Liu, Y., Tian, D., Wang, C., Wang, S., Cheng, J., Hu, M., Fang, M., & Gao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0127-9 · Cited by 234
Wang, Y., Jiang, W., He, Q., Wang, C., Wang, B., Zhou, P., Dong, N., & Tong, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0158-2 · Cited by 219
GLUCOCOVID investigators, Corral-Gudino, L., Bahamonde, A., Arnaiz-Revillas, F., Gómez-Barquero, J., Abadía-Otero, J., García-Ibarbia, C., Mora, V., Cerezo-Hernández, A., Hernández, J. L., et al. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01805-8 · Cited by 214
Self-citationDe Luca, G., Cavalli, G., Campochiaro, C., Della-Torre, E., Angelillo, P., Tomelleri, A., Boffini, N., Tentori, S., Mette, F., Farina, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30170-3 · Cited by 202
Fernández‐Cruz, A., Ruíz‐Antorán, B., Muñoz‐Gómez, A., Sancho‐López, A., Mills-Sánchez, P., Centeno-Soto, G. A., Blanco‐Alonso, S., Garachana, L. J., Gómez, A. G., Alijo, Á. V., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01168-20 · Cited by 157
Adjuvant corticosteroid therapy for critically ill patients with COVID-19
Lu, X., Chen, T., Wang, Y., Wang, J., Zhang, B., Li, Y., & Yan, F. (2020) · Critical Care · doi:10.1186/s13054-020-02964-w · Cited by 146
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
Fang, X., Mei, Q., Yang, T., Li, L., Wang, Y., Tong, F., Geng, S., & Pan, A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.039 · Cited by 143
Endothelial glucocorticoid receptor is required for protection against sepsis
Goodwin, J. E., Feng, Y., Velazquez, H., & Sessa, W. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210200110 · Cited by 142
Meduri, G. U., Siemieniuk, R. A. C., Ness, R. A., & Seyler, S. J. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0321-9 · Cited by 130
Guo, K., Zhao, F., Guo, Y., Li, F. L., Zhu, L., & Zheng, W. (2014) · The Bone & Joint Journal · doi:10.1302/0301-620x.96b2.31935 · Cited by 93
Risk-adapted Treatment Strategy For COVID-19 Patients
Zheng, C., Wang, J., Guo, H., Lu, Z., Ma, Y., Zhu, Y., Xia, D., Wang, Y., He, H., Zhou, J., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.047 · Cited by 89
Li, S., Hu, Z., & Song, X. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa829 · Cited by 66
The Effect of Steroid Use in Hospitalized Adults With Respiratory Syncytial Virus-Related Illness
Lee, F. E.-H., Walsh, E. E., & Falsey, A. R. (2011) · CHEST Journal · doi:10.1378/chest.11-0047 · Cited by 63
Glucocorticoids with or without Fludrocortisone in Septic Shock
Venkatesh, B., Finfer, S. R., & Myburgh, J. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1804993 · Cited by 16
Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials
Martino, E. A., Redaelli, M. B., Sardo, S., Lembo, R., Giordano, V. F., Winterton, D., Ruggeri, L., Hajjar, L. A., Zangrillo, A., & Landoni, G. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.04.017 · Cited by 12
Self-citation
Cited by
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J. A. C., Murthy, S., Diaz, J. V., Slutsky, A. S., Villar, J., Angus, D. C., Annane, D., Azevedo, L. C. P., Berwanger, O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17023 · Cited by 2,257
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Qadir, N., Sahetya, S., Munshi, L., Summers, C., Abrams, D., Beitler, J., Bellani, G., Brower, R. G., Burry, L., Chen, J.-T., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202311-2011st · Cited by 444
Alhazzani, W., Evans, L., Alshamsi, F., Møller, M. H., Ostermann, M., Prescott, H. C., Arabi, Y. M., Loeb, M., Ng Gong, M., Fan, E., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004899 · Cited by 417
Metadata
- Authors
- Jeronimo, C. M. P., Farias, M. E. L., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Safe, I. P., Borba, M. G. S., Netto, R. L. A., Maciel, A. B. S., Neto, J. R. S., Oliveira, L. B., Figueiredo, E. F. G., Oliveira Dinelly, K. M., de Almeida Rodrigues, M. G., Brito, M., Mourão, M. P. G., Pivoto João, G. A., Hajjar, L. A., Bassat, Q., Romero, G. A. S., Naveca, F. G., Vasconcelos, H. L., de Araújo Tavares, M., Brito-Sousa, J. D., Costa, F. T. M., Nogueira, M. L., Baía-da-Silva, D. C., Xavier, M. S., Monteiro, W. M., Lacerda, M. V. G., Metcovid Team, de Lemos Vasconcelos, A., Praia Marins, A. F., de Oliveira Trindade, A., Mendes Záu, A. S., de Oliveira, A. C., Azevedo Furtado, A. C., Coelho Rocha, A. P., da Silva Souza, A., de Souza Dias, A., Belém, A., dos Santos, A. G. R., da Silva Sousa, A. M., da Silva, B. F., Franco, B. L., da Silva, B. M., da Costa, B. L. G., Sato Barros do Amaral, C. M. S., Judice, C. C., de Morais, C. E. P., Camilo, C. C., Sena da Silva, D. S., Gomes Duarte, D. C., da Silva, E. G. N., da Silva Lemos, E., de Fátima Ponte Frota, E., do Nascimento, E. F., de Almeida, E. S., Marques, E. A., de Almeida, E. M. M., da Silva, E. L., dos Santos, E. G., da Silva Oliveira, E., Martins Shimizu, F. M., de Souza, F. R. F., da Silva do Vale, F., dos Santos de Almeida Lima, F., da Fonseca, F. H. J., Fontenelle, F. A., de Azevedo Furtado, F., Da Silva Pereira, G., Bezerra, G. A., Maciel Salazar, G. K., da Silva Pereira, H., de Melo, H. F., Oliveira, I. N., Pereira Filho, I. V., Gomes, J. V., e Silva Rosa, J., Lemos, J. M., Brutus, J. N., Pessoa, K. P., Costa Rodrigues, L. D., Barros Cirino, L. E., Mourão Filho, L. F., Moura, L., Barbosa, L. R. P., de Souza, L. P., Oliveira, L. B., de Lima Ferreira, L. C., dos Santos, M. M., da Silva, M. V. R., Rodrigues, M. P., de Menezes, M. T., dos Santos Mota, M. M., Freire, M., Corrêa, N. F., Rocha, N. M., Bittencourt, N., de Melo Silva, N. G., de Oliveira Saraiva, P., de Sousa Monteiro, Q., dos Santos, R. T., Freire, R. S., de Araújo Pinto, R. A., Ferreira, R. B., de Lima, R. S., de Melo, R. F. T., Saenz, S. T., Alvarez Fernandes, S. S., Vítor-Silva, S., de Oliveira, T. M. R., Tavella, T. A., Câmara, T. T., Santos, T. C., Pinto, T. S., dos Santos, T. W. R., do Nascimento, V. A., Sousa Barbosa, W. P., de Melo, W. F., & Salgado Sobrinho, W. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-12
- Volume
- 72
- Issue
- 9
- Pages
- e373-e381
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3048510827
- Cited by
- 434
- References
- 37
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.